Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2024

05-01-2024 | Crohn's Disease | Case Report

Takayasu’s arteritis associated with Crohn’s disease treated with infliximab

Authors: Hiroyuki Ariga, Yusuke Chino, Takeshi Ojima, Satoshi Suzuki, Kenta Okada, Junya Kashimura

Published in: Clinical Journal of Gastroenterology | Issue 2/2024

Login to get access

Abstract

A 23-year-old woman presented with fever, diarrhea, bloody stools, and arthralgia that did not improve despite previous treatments and was diagnosed with Crohn’s disease. Remission was achieved after the introduction of infliximab, nutritional therapy, and 5-aminosalicylic acid treatment. However, the patient’s blood sedimentation rate remained elevated without symptom recurrence, except for abdominal pain in the following year. Aortic wall thickening in the thoracic descending aorta was also observed on computed tomography. Accumulation in the thoracic descending aorta and abdominal aorta was confirmed using positron emission tomography–computed tomography. The patient was diagnosed with Takayasu’s arteritis. The patient’s abdominal symptoms resolved, and her blood sedimentation rate normalized after steroid administration.
Literature
2.
go back to reference Hata A, Noda M, Moriwaki R, et al. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(Suppl):S155–63.CrossRefPubMed Hata A, Noda M, Moriwaki R, et al. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(Suppl):S155–63.CrossRefPubMed
3.
go back to reference de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.CrossRefPubMed de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014;48–49:79–83.CrossRefPubMed
5.
go back to reference Yassinger S, Adelman R, Cantor D, et al. Association of inflammatory bowel disease and large vascular lesions. Gastroenterology. 1976;71:844–6.CrossRefPubMed Yassinger S, Adelman R, Cantor D, et al. Association of inflammatory bowel disease and large vascular lesions. Gastroenterology. 1976;71:844–6.CrossRefPubMed
6.
go back to reference Reny JL, Paul JF, Lefèbvre C, et al. Association of Takayasu’s arteritis and Crohn’s disease. Results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris). 2003;154:85–90.PubMed Reny JL, Paul JF, Lefèbvre C, et al. Association of Takayasu’s arteritis and Crohn’s disease. Results of a study on 44 Takayasu patients and review of the literature. Ann Med Interne (Paris). 2003;154:85–90.PubMed
7.
go back to reference Farrant M, Mason JC, Wong NA, et al. Takayasu’s arteritis following Crohn’s disease in a young woman: any evidence for a common pathogenesis? World J Gastroenterol. 2008;14:4087–90.CrossRefPubMedPubMedCentral Farrant M, Mason JC, Wong NA, et al. Takayasu’s arteritis following Crohn’s disease in a young woman: any evidence for a common pathogenesis? World J Gastroenterol. 2008;14:4087–90.CrossRefPubMedPubMedCentral
8.
go back to reference Kusunoki R, Ishihara S, Sato M, et al. rare case of Takayasu’s arteritis associated with Crohn’s disease. Intern Med. 2011;50:1581–5.CrossRefPubMed Kusunoki R, Ishihara S, Sato M, et al. rare case of Takayasu’s arteritis associated with Crohn’s disease. Intern Med. 2011;50:1581–5.CrossRefPubMed
9.
go back to reference Yilmaz N, Can M, Alibaz-Oner F, et al. Clinically silent Crohn’s disease in a patient with Takayasu’s arteritis unresponsive to conventional therapies. Rheumatol Int. 2013;33:3091–3.CrossRefPubMed Yilmaz N, Can M, Alibaz-Oner F, et al. Clinically silent Crohn’s disease in a patient with Takayasu’s arteritis unresponsive to conventional therapies. Rheumatol Int. 2013;33:3091–3.CrossRefPubMed
10.
go back to reference Pallone F, Monteleone G. Mechanisms of tissue damage in inflammatory bowel disease. Curr Opin Gastroenterol. 2001;17:307–12.CrossRefPubMed Pallone F, Monteleone G. Mechanisms of tissue damage in inflammatory bowel disease. Curr Opin Gastroenterol. 2001;17:307–12.CrossRefPubMed
11.
go back to reference Terao C, Matsumura T, Yoshifuji H, et al. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol. 2015;67:2226–32.CrossRefPubMed Terao C, Matsumura T, Yoshifuji H, et al. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol. 2015;67:2226–32.CrossRefPubMed
12.
go back to reference Akiyama S, Fujii T, Matsuoka K, et al. Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol. 2017;32:1011–7.CrossRefPubMed Akiyama S, Fujii T, Matsuoka K, et al. Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol. 2017;32:1011–7.CrossRefPubMed
13.
go back to reference Simon S, Schittko G, Bösenberg H, et al. Fulminant course of a Takayasu’s arteritis and rare mesenteric arterial maninfestion. Z Rheumatol. 2006;65:522–6. Simon S, Schittko G, Bösenberg H, et al. Fulminant course of a Takayasu’s arteritis and rare mesenteric arterial maninfestion. Z Rheumatol. 2006;65:522–6.
14.
go back to reference Tripathy NK, Gupta PC, Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu’s arteritis. Clin Immunol. 2006;118:154–8.CrossRefPubMed Tripathy NK, Gupta PC, Nityanand S. High TNF-alpha and low IL-2 producing T cells characterize active disease in Takayasu’s arteritis. Clin Immunol. 2006;118:154–8.CrossRefPubMed
16.
go back to reference Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn’s disease activity index National cooperative Crohn’s disease study. Gastroenterology. 1976;70:439–44.CrossRefPubMed Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn’s disease activity index National cooperative Crohn’s disease study. Gastroenterology. 1976;70:439–44.CrossRefPubMed
17.
go back to reference Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.CrossRefPubMedPubMedCentral Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.CrossRefPubMedPubMedCentral
18.
go back to reference Sy A, Khalidi N, Dehghan N, et al. Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature. Semin Arthritis Rheum. 2016;45:475–82.CrossRefPubMed Sy A, Khalidi N, Dehghan N, et al. Vasculitis in patients with inflammatory bowel diseases: a study of 32 patients and systematic review of the literature. Semin Arthritis Rheum. 2016;45:475–82.CrossRefPubMed
20.
go back to reference Hall S, Barr W, Lie JT, et al. Takayasu’s arteritis. A study of 32 North American patients. Medicine. 1985;64:88–99.CrossRef Hall S, Barr W, Lie JT, et al. Takayasu’s arteritis. A study of 32 North American patients. Medicine. 1985;64:88–99.CrossRef
21.
22.
go back to reference Nakaoka Y, Isobe M, Tanaka Y, et al. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology (Oxford). 2020;59:2427–34.CrossRefPubMed Nakaoka Y, Isobe M, Tanaka Y, et al. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology (Oxford). 2020;59:2427–34.CrossRefPubMed
23.
go back to reference Domènech E, Garcia-Planella E, Olazábal A, et al. Abdominal aortitis associated with Crohn’s disease. Dig Dis Sci. 2005;50:1122–3.CrossRefPubMed Domènech E, Garcia-Planella E, Olazábal A, et al. Abdominal aortitis associated with Crohn’s disease. Dig Dis Sci. 2005;50:1122–3.CrossRefPubMed
24.
go back to reference Kellermayer R, Jain AK, Ferry G, et al. Clinical challenges and images in GI. Aortitis as a rare complication of Crohn’s disease. Gastroenterology. 2008;134:668–9.CrossRefPubMed Kellermayer R, Jain AK, Ferry G, et al. Clinical challenges and images in GI. Aortitis as a rare complication of Crohn’s disease. Gastroenterology. 2008;134:668–9.CrossRefPubMed
26.
go back to reference Katoh N, Kubota M, Shimojima Y, et al. Takayasu’s arteritis in a patient with Crohn’s disease: an unexpected association during infliximab therapy. Intern Med. 2010;49:179–82.CrossRefPubMed Katoh N, Kubota M, Shimojima Y, et al. Takayasu’s arteritis in a patient with Crohn’s disease: an unexpected association during infliximab therapy. Intern Med. 2010;49:179–82.CrossRefPubMed
27.
go back to reference Ratuapli S, Mazlumzadeh M, Gurudu S, et al. Coexisting Crohn’s disease and Takayasu’s arteritis in two patients treated with Anti-TNF-α therapies. Case Rep Gastroenterol. 2010;4:35–40.CrossRefPubMedPubMedCentral Ratuapli S, Mazlumzadeh M, Gurudu S, et al. Coexisting Crohn’s disease and Takayasu’s arteritis in two patients treated with Anti-TNF-α therapies. Case Rep Gastroenterol. 2010;4:35–40.CrossRefPubMedPubMedCentral
28.
go back to reference Osman M, Aaron S, Noga M, et al. Takayasu’s arteritis progression on anti-TNF biologics: a case series. Clin Rheumatol. 2011;30:703–6.CrossRefPubMed Osman M, Aaron S, Noga M, et al. Takayasu’s arteritis progression on anti-TNF biologics: a case series. Clin Rheumatol. 2011;30:703–6.CrossRefPubMed
29.
go back to reference Miyakawa M, Tanaka H, Yamashita M, et al. A case of Takayasu’s arteritis detected in a patient with Crohn’s disease following infliximab treatment. Nihon Shokakibyo Gakkai Zasshi. 2016;113:1761–8.PubMed Miyakawa M, Tanaka H, Yamashita M, et al. A case of Takayasu’s arteritis detected in a patient with Crohn’s disease following infliximab treatment. Nihon Shokakibyo Gakkai Zasshi. 2016;113:1761–8.PubMed
30.
go back to reference Talathi S, Mannion M, Colvin E, et al. Aortitis with an Aneurysm at initial presentation of Crohn disease. J Pediatr Gastroenterol Nutr. 2018;67:e12–3.CrossRefPubMed Talathi S, Mannion M, Colvin E, et al. Aortitis with an Aneurysm at initial presentation of Crohn disease. J Pediatr Gastroenterol Nutr. 2018;67:e12–3.CrossRefPubMed
31.
go back to reference Takeuchi I, Kawai T, Nambu M, et al. X-linked inhibitor of apoptosis protein deficiency complicated with Crohn’s disease-like enterocolitis and Takayasu arteritis: a case report. Clin Immunol. 2020;217: 108495.CrossRefPubMed Takeuchi I, Kawai T, Nambu M, et al. X-linked inhibitor of apoptosis protein deficiency complicated with Crohn’s disease-like enterocolitis and Takayasu arteritis: a case report. Clin Immunol. 2020;217: 108495.CrossRefPubMed
32.
go back to reference Kollen L, Werner O, Gavotto A. Uncommon cause of chest pain in a 9-year-old boy with Crohn’s disease. Gastroenterology. 2020;158:2055–7.CrossRefPubMed Kollen L, Werner O, Gavotto A. Uncommon cause of chest pain in a 9-year-old boy with Crohn’s disease. Gastroenterology. 2020;158:2055–7.CrossRefPubMed
33.
go back to reference Polyakova I, Iannucci G, George R, et al. Simultaneous presentation of Crohn’s disease and Takayasu arteritis in a teenage patient. J Investig Med High Impact Case Rep. 2020;8:2324709620977317.PubMedPubMedCentral Polyakova I, Iannucci G, George R, et al. Simultaneous presentation of Crohn’s disease and Takayasu arteritis in a teenage patient. J Investig Med High Impact Case Rep. 2020;8:2324709620977317.PubMedPubMedCentral
Metadata
Title
Takayasu’s arteritis associated with Crohn’s disease treated with infliximab
Authors
Hiroyuki Ariga
Yusuke Chino
Takeshi Ojima
Satoshi Suzuki
Kenta Okada
Junya Kashimura
Publication date
05-01-2024
Publisher
Springer Nature Singapore
Published in
Clinical Journal of Gastroenterology / Issue 2/2024
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-023-01904-9

Other articles of this Issue 2/2024

Clinical Journal of Gastroenterology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.